DefEYE is an eye care startup that is expanding quickly with the goal of changing and customizing therapeutic procedures.
DefEYE has raised $12.0M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
DefEYE's investors include Celularity, ExSight Ventures, Michael Nissen.
DefEYE is headquartered in Sarasota, United States.
DefEYE is an eye care startup that is expanding quickly with the goal of changing and customizing therapeutic procedures.
DefEYE is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DefEYE — Funding & Investors." VCBacked, October 30, 2025, https://www.vcbacked.co/company/defeye. Accessed August 15, 2026.
VCBacked. (2025). DefEYE — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/defeye
{{cite web |title=DefEYE — Funding & Investors |url=https://www.vcbacked.co/company/defeye |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated